NCT02064712

Brief Summary

The purpose of this study is to determine an optimal strategy to wean nasal continuous positive airway pressure (NCPAP) in preterm babies. The investigators hypothesize that babies that are taken off NCPAP at lower settings will need fewer total days on NCPAP than those babies taken off at higher settings.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
226

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 14, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 17, 2014

Completed
7 months until next milestone

Study Start

First participant enrolled

September 1, 2014

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2018

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2018

Completed
Last Updated

October 22, 2018

Status Verified

October 1, 2018

Enrollment Period

3.7 years

First QC Date

February 14, 2014

Last Update Submit

October 19, 2018

Conditions

Keywords

Continuous Positive Airway Pressure

Outcome Measures

Primary Outcomes (1)

  • Total days of NCPAP

    Total number of days of CPAP therapy during the hospital stay

    Until hospital discharge or 1 year of life

Secondary Outcomes (2)

  • Length of hospital stay

    Until hospital discharge or 1 year of life

  • Duration of oxygen supplementation

    Until hospital discharge or 1 year of life

Study Arms (2)

Low CPAP Wean

ACTIVE COMPARATOR

NCPAP weaned to 5cm H2O for minimum of 24h, and if the neonate remains clinically stable as defined, wean in 1cm increments to 3cm H2O for minimum of 24h, at which time move to room air or 1L/min nasal cannula if supplemental O2 is required.

Other: Low CPAP Wean

High CPAP Wean

ACTIVE COMPARATOR

NCPAP weaned to 5cm H2O for a minimum of 24h, and if the neonate remains clinically stable, move to room air or 1L/min nasal cannula if supplemental O2 is required.

Other: High CPAP Wean

Interventions

Infants receive NCPAP by Hudson nasal prongs.

Low CPAP Wean

Infants receive NCPAP by Hudson nasal prongs.

High CPAP Wean

Eligibility Criteria

AgeUp to 32 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Neonates ≤32wks GA requiring NCPAP in the delivery room or NICU for increasing respiratory distress or post-extubation from mechanical ventilation.

You may not qualify if:

  • Neonates requiring NCPAP for less than 48 hours
  • Congenital anomalies
  • Need for surgery
  • Transfer to a different facility
  • Grade 3-4 intraventricular hemorrhage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Parkland Memorial Hospital

Dallas, Texas, 75235, United States

Location

Related Publications (1)

  • Kakkilaya V, Tang A, Wagner S, Ridpath J, Ibrahim J, Brown LS, Rosenfeld CR. Discontinuing Nasal Continuous Positive Airway Pressure in Infants </=32 Weeks of Gestational Age: A Randomized Control Trial. J Pediatr. 2021 Mar;230:93-99.e3. doi: 10.1016/j.jpeds.2020.10.045. Epub 2020 Oct 28.

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Venkat Kakkilaya, MD

    UT Southwestern

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 14, 2014

First Posted

February 17, 2014

Study Start

September 1, 2014

Primary Completion

May 1, 2018

Study Completion

October 1, 2018

Last Updated

October 22, 2018

Record last verified: 2018-10

Locations